Compare ALXO & OPBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALXO | OPBK |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.9M | 233.2M |
| IPO Year | 2020 | 2018 |
| Metric | ALXO | OPBK |
|---|---|---|
| Price | $1.94 | $15.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $3.50 | ★ $16.50 |
| AVG Volume (30 Days) | ★ 818.2K | 34.4K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.73% |
| EPS Growth | ★ 26.36 | 23.74 |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $3,204,000.00 |
| Revenue This Year | N/A | $16.07 |
| Revenue Next Year | N/A | $11.60 |
| P/E Ratio | ★ N/A | $32.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.51 | $12.41 |
| 52 Week High | $2.66 | $16.80 |
| Indicator | ALXO | OPBK |
|---|---|---|
| Relative Strength Index (RSI) | 46.61 | 57.64 |
| Support Level | $1.56 | $13.76 |
| Resistance Level | $2.27 | N/A |
| Average True Range (ATR) | 0.13 | 0.59 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 22.58 | 48.94 |
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
OP Bancorp operates its commercial community banking activities through Open Bank its wholly owned banking subsidiary. It provides commercial banking services to small and medium-sized businesses, their owners, and retail customers, with a focus on the Korean-American community. The bank currently operate twelve full service branches: nine branches across Los Angeles and Orange Counties in California, as well as one branch each in Santa Clara, California; Carrollton, Texas; and Las Vegas, Nevada. Additionally, it maintains five loan production offices located in Pleasanton, California; Atlanta, Georgia; Aurora, Colorado; Lynnwood, Washington; and Fairfax, Virginia. Substantially all its business activities are conducted through the Bank.